更正：黄芪-蝎药物对通过调节gdpdp4 -2/PI3K/AKT/mTOR通路和自噬抑制前列腺癌的发展。

IF 4.4 2区医学 Q1 PHARMACOLOGY & PHARMACY

Frontiers in Pharmacology Pub Date : 2025-03-20 eCollection Date: 2025-01-01 DOI:10.3389/fphar.2025.1417603

Xujun You, Yongrong Wu, Qixin Li, Wen Sheng, Qing Zhou, Wei Fu

引用次数: 0

摘要

[这更正了文章DOI: 10.3389/fphar.2022.895696.]。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Corrigendum: Astragalus-Scorpion drug pair inhibits the development of prostate cancer by regulating GDPD4-2/PI3K/AKT/mTOR pathway and autophagy.

[This corrects the article DOI: 10.3389/fphar.2022.895696.].

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Frontiers in Pharmacology PHARMACOLOGY & PHARMACY-

CiteScore

7.80

自引率

8.90%

发文量

5163

审稿时长

14 weeks

期刊介绍： Frontiers in Pharmacology is a leading journal in its field, publishing rigorously peer-reviewed research across disciplines, including basic and clinical pharmacology, medicinal chemistry, pharmacy and toxicology. Field Chief Editor Heike Wulff at UC Davis is supported by an outstanding Editorial Board of international researchers. This multidisciplinary open-access journal is at the forefront of disseminating and communicating scientific knowledge and impactful discoveries to researchers, academics, clinicians and the public worldwide.